{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:28:16Z","timestamp":1793320096680,"version":"4.5.0"},"reference-count":30,"publisher":"Walter de Gruyter GmbH","issue":"9","license":[{"start":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:00:00Z","timestamp":1758153600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,25]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_jpm-2025-0190_abs_001\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>This study aimed to compare noninvasive liver fibrosis markers, including the Aspartate Aminotransferase Platelet Ratio Index (APRI) and FIB-4, between patients with hypertensive disorders of pregnancy (HDP) and healthy controls and to investigate the association between these markers and adverse maternal and perinatal outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jpm-2025-0190_abs_002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this retrospective case-control study, 205 patients with HDP and 192 normotensive controls were included for evaluation. Demographic data, laboratory findings, and maternal and perinatal outcomes were compared. FIB-4 and APRI scores were calculated using second-trimester AST, ALT, and platelet levels. ROC curve analysis was used to assess the predictive accuracy of these indices for HELLP syndrome and other complications. Linear regression analysis was applied to evaluate the parameters associated with the FIB-4\u00a0score.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jpm-2025-0190_abs_003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>FIB-4 and APRI scores were significantly higher in patients with HDP compared to controls (p&lt;0.05). Among patients with severe preeclampsia and HELLP syndrome, fibrosis scores were markedly elevated. FIB-4 and APRI showed excellent diagnostic performance for HELLP syndrome (AUC: 0.976 and 0.992, respectively), with optimal cutoffs of 1.52 and 0.7. However, their predictive role for general adverse maternal and perinatal outcomes was limited. In multivariate regression, systolic blood pressure, maternal age, and adverse maternal outcomes were independent predictors of increased FIB-4 scores (p&lt;0.05).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jpm-2025-0190_abs_004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>FIB-4 and APRI may be considered simple, noninvasive indices that could contribute to early risk stratification for HELLP syndrome among patients with HDP. Although their predictive capacity remains to be validated in larger prospective studies, they may offer preliminary insights into hepatic dysfunction during pregnancy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/jpm-2025-0190","type":"journal-article","created":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T01:08:58Z","timestamp":1758244138000},"page":"1230-1237","source":"Crossref","is-referenced-by-count":3,"title":["Liver fibrosis markers as predictors of adverse outcomes in pregnancy-related hypertensive disorders"],"prefix":"10.1515","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1066-6055","authenticated-orcid":false,"given":"Murad","family":"Gezer","sequence":"first","affiliation":[{"name":"Department of Perinatology , Zeynep K\u00e2mil Women\u2019s and Children\u2019s Disease Training and Research Hospital , Istanbul , T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00dcmit","family":"Ta\u015fdemir","sequence":"additional","affiliation":[{"name":"Department of Perinatology , Zeynep K\u00e2mil Women\u2019s and Children\u2019s Disease Training and Research Hospital , Istanbul , T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mucize Eri\u00e7","family":"\u00d6zdemir","sequence":"additional","affiliation":[{"name":"Department of Perinatology , Zeynep K\u00e2mil Women\u2019s and Children\u2019s Disease Training and Research Hospital , Istanbul , T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sevdenur","family":"Yi\u011fit","sequence":"additional","affiliation":[{"name":"Department of Obstetric and Gynecology , Zeynep K\u00e2mil Women\u2019s and Children\u2019s Disease Training and Research Hospital , Istanbul , T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00fc\u015fra","family":"Cambaztepe","sequence":"additional","affiliation":[{"name":"Department of Perinatology , Zeynep K\u00e2mil Women\u2019s and Children\u2019s Disease Training and Research Hospital , Istanbul , T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oya","family":"Demirci","sequence":"additional","affiliation":[{"name":"Department of Perinatology , Zeynep K\u00e2mil Women\u2019s and Children\u2019s Disease Training and Research Hospital , Istanbul , T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2025,9,18]]},"reference":[{"key":"2025121815535097974_j_jpm-2025-0190_ref_001","doi-asserted-by":"crossref","unstructured":"Timpka, S, Markovitz, A, Schyman, T, Mogren, I, Fraser, A, Franks, PW, et al.. Midlife development of type 2 diabetes and hypertension in women by history of hypertensive disorders of pregnancy. Cardiovasc Diabetol 2018;17:124. https:\/\/doi.org\/10.1186\/s12933-018-0764-2.","DOI":"10.1186\/s12933-018-0764-2"},{"key":"2025121815535097974_j_jpm-2025-0190_ref_002","doi-asserted-by":"crossref","unstructured":"C\u00edfkov\u00e1, R. Hypertension in pregnancy: a diagnostic and therapeutic overview. High Blood Pres Cardiovasc Prev 2023;30:289\u2013303. https:\/\/doi.org\/10.1007\/s40292-023-00582-5.","DOI":"10.1007\/s40292-023-00582-5"},{"key":"2025121815535097974_j_jpm-2025-0190_ref_003","doi-asserted-by":"crossref","unstructured":"Yang, Y, Le Ray, I, Zhu, J, Zhang, J, Hua, J, Reilly, M. Preeclampsia prevalence, risk factors, and pregnancy outcomes in Sweden and China. JAMA Netw Open 2021;4:e218401. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.8401.","DOI":"10.1001\/jamanetworkopen.2021.8401"},{"key":"2025121815535097974_j_jpm-2025-0190_ref_004","doi-asserted-by":"crossref","unstructured":"Alese, MO, Moodley, J, Naicker, T. Preeclampsia and HELLP syndrome, the role of the liver. J\u00a0Matern Fetal Neonatal Med 2021;34:117\u201323. https:\/\/doi.org\/10.1080\/14767058.2019.1572737.","DOI":"10.1080\/14767058.2019.1572737"},{"key":"2025121815535097974_j_jpm-2025-0190_ref_005","doi-asserted-by":"crossref","unstructured":"Chang, KJ, Seow, KM, Chen, KH. Preeclampsia: recent advances in predicting, preventing, and managing the maternal and fetal life-threatening condition. Int J Environ Res Publ Health 2023;20. https:\/\/doi.org\/10.3390\/ijerph20042994.","DOI":"10.3390\/ijerph20042994"},{"key":"2025121815535097974_j_jpm-2025-0190_ref_006","doi-asserted-by":"crossref","unstructured":"Naruse, K. Liver biomarkers and preeclampsia: an easy-accessible prediction method of the disease. Hypertens Res 2024;47:2610\u20131. https:\/\/doi.org\/10.1038\/s41440-024-01804-6.","DOI":"10.1038\/s41440-024-01804-6"},{"key":"2025121815535097974_j_jpm-2025-0190_ref_007","doi-asserted-by":"crossref","unstructured":"Vanl\u0131 Tonyal\u0131, N, Karabay, G, Aktemur, G, Tokg\u00f6z \u00c7ak\u0131r, B, \u015eeyhanl\u0131, Z, \u00c7etin, S, et al.. Evaluation of APRI and FIB-4 indices in early and late-onset preeclampsia. Eur Res J 2025;11:363\u201370. https:\/\/doi.org\/10.18621\/eurj.1609129.","DOI":"10.18621\/eurj.1609129"},{"key":"2025121815535097974_j_jpm-2025-0190_ref_008","doi-asserted-by":"crossref","unstructured":"Magee, LA, Brown, MA, Hall, DR, Gupte, S, Hennessy, A, Karumanchi, SA, et al.. The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice. Pregnancy Hypertens 2022;27:148\u201369. https:\/\/doi.org\/10.1016\/j.preghy.2021.09.008.","DOI":"10.1016\/j.preghy.2021.09.008"},{"key":"2025121815535097974_j_jpm-2025-0190_ref_009","doi-asserted-by":"crossref","unstructured":"Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin. Number 222. Obstet Gynecol 2020;135:e237\u201360.","DOI":"10.1097\/AOG.0000000000003891"},{"key":"2025121815535097974_j_jpm-2025-0190_ref_010","doi-asserted-by":"crossref","unstructured":"Sibai, BM. Diagnosis, prevention, and management of eclampsia. Obstet Gynecol 2005;105:402\u201310. https:\/\/doi.org\/10.1097\/01.aog.0000152351.13671.99.","DOI":"10.1097\/01.AOG.0000152351.13671.99"},{"key":"2025121815535097974_j_jpm-2025-0190_ref_011","doi-asserted-by":"crossref","unstructured":"Sibai, BM. Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet Gynecol 2004;103:981\u201391. https:\/\/doi.org\/10.1097\/01.aog.0000126245.35811.2a.","DOI":"10.1097\/01.AOG.0000126245.35811.2a"},{"key":"2025121815535097974_j_jpm-2025-0190_ref_012","doi-asserted-by":"crossref","unstructured":"Lees, CC, Stampalija, T, Baschat, A, da Silva Costa, F, Ferrazzi, E, Figueras, F, et al.. ISUOG Practice Guidelines: diagnosis and management of small-for-gestational-age fetus and fetal growth restriction. Ultrasound Obstet Gynecol 2020;56:298\u2013312. https:\/\/doi.org\/10.1002\/uog.22134.","DOI":"10.1002\/uog.22134"},{"key":"2025121815535097974_j_jpm-2025-0190_ref_013","doi-asserted-by":"crossref","unstructured":"Blencowe, H, Cousens, S, Oestergaard, MZ, Chou, D, Moller, AB, Narwal, R, et al.. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet 2012;379:2162\u201372. https:\/\/doi.org\/10.1016\/s0140-6736(12)60820-4.","DOI":"10.1016\/S0140-6736(12)60820-4"},{"key":"2025121815535097974_j_jpm-2025-0190_ref_014","doi-asserted-by":"crossref","unstructured":"K, CA, Basel, PL, Singh, S. Low birth weight and its associated risk factors: health facility-based case-control study. PLoS One 2020;15:e0234907. https:\/\/doi.org\/10.1371\/journal.pone.0234907.","DOI":"10.1371\/journal.pone.0234907"},{"key":"2025121815535097974_j_jpm-2025-0190_ref_015","doi-asserted-by":"crossref","unstructured":"Lai, JC, Liang, LY, Wong, GL. Noninvasive tests for liver fibrosis in 2024: are there different scales for different diseases? Gastroenterol Rep (Oxf) 2024;12:goae024. https:\/\/doi.org\/10.1093\/gastro\/goae024.","DOI":"10.1093\/gastro\/goae024"},{"key":"2025121815535097974_j_jpm-2025-0190_ref_016","doi-asserted-by":"crossref","unstructured":"Hutcheon, JA, Lisonkova, S, Joseph, KS. Epidemiology of preeclampsia and the other hypertensive disorders of pregnancy. Best Pract Res Clin Obstet Gynaecol 2011;25:391\u2013403. https:\/\/doi.org\/10.1016\/j.bpobgyn.2011.01.006.","DOI":"10.1016\/j.bpobgyn.2011.01.006"},{"key":"2025121815535097974_j_jpm-2025-0190_ref_017","doi-asserted-by":"crossref","unstructured":"Metoki, H, Iwama, N, Hamada, H, Satoh, M, Murakami, T, Ishikuro, M, et al.. Hypertensive disorders of pregnancy: definition, management, and out-of-office blood pressure measurement. Hypertens Res 2022;45:1298\u2013309. https:\/\/doi.org\/10.1038\/s41440-022-00965-6.","DOI":"10.1038\/s41440-022-00965-6"},{"key":"2025121815535097974_j_jpm-2025-0190_ref_018","doi-asserted-by":"crossref","unstructured":"Khedagi, AM, Bello, NA. Hypertensive disorders of pregnancy. Cardiol Clin 2021;39:77\u201390. https:\/\/doi.org\/10.1016\/j.ccl.2020.09.005.","DOI":"10.1016\/j.ccl.2020.09.005"},{"key":"2025121815535097974_j_jpm-2025-0190_ref_019","doi-asserted-by":"crossref","unstructured":"Frank Wolf, M, Peleg, D, Kariv Silberstein, N, Assy, N, Djibre, A, Ben-Shachar, I. Correlation between changes in liver stiffness and preeclampsia as shown by transient elastography. Hypertens Pregnancy 2016;35:536\u201341. https:\/\/doi.org\/10.1080\/10641955.2016.1197934.","DOI":"10.1080\/10641955.2016.1197934"},{"key":"2025121815535097974_j_jpm-2025-0190_ref_020","doi-asserted-by":"crossref","unstructured":"Serra, C, Dajti, E, De Molo, C, Montaguti, E, Porro, A, Seidenari, A, et al.. Utility of Doppler-ultrasound and liver elastography in the evaluation of patients with suspected pregnancy-related liver disease. J\u00a0Clin Med 2023;12. https:\/\/doi.org\/10.3390\/jcm12041653.","DOI":"10.3390\/jcm12041653"},{"key":"2025121815535097974_j_jpm-2025-0190_ref_021","doi-asserted-by":"crossref","unstructured":"Imajo, K, Kessoku, T, Honda, Y, Tomeno, W, Ogawa, Y, Mawatari, H, et al.. Magnetic resonance imaging more accurately classifies steatosis and fibrosis in patients with nonalcoholic fatty liver disease than transient elastography. Gastroenterology 2016;150:626\u201337.e7. https:\/\/doi.org\/10.1053\/j.gastro.2015.11.048.","DOI":"10.1053\/j.gastro.2015.11.048"},{"key":"2025121815535097974_j_jpm-2025-0190_ref_022","doi-asserted-by":"crossref","unstructured":"Chalasani, N, Younossi, Z, Lavine, JE, Charlton, M, Cusi, K, Rinella, M, et al.. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology 2018;67:328\u201357. https:\/\/doi.org\/10.1002\/hep.29367.","DOI":"10.1002\/hep.29367"},{"key":"2025121815535097974_j_jpm-2025-0190_ref_023","doi-asserted-by":"crossref","unstructured":"Abildgaard, U, Heimdal, K. Pathogenesis of the syndrome of hemolysis, elevated liver enzymes, and low platelet count (HELLP): a review. Eur J Obstet Gynecol Reprod Biol 2013;166:117\u201323. https:\/\/doi.org\/10.1016\/j.ejogrb.2012.09.026.","DOI":"10.1016\/j.ejogrb.2012.09.026"},{"key":"2025121815535097974_j_jpm-2025-0190_ref_024","doi-asserted-by":"crossref","unstructured":"Ammon, FJ, Kohlhaas, A, Elshaarawy, O, Mueller, J, Bruckner, T, Sohn, C, et al.. Liver stiffness reversibly increases during pregnancy and independently predicts preeclampsia. World J Gastroenterol 2018;24:4393\u2013402. https:\/\/doi.org\/10.3748\/wjg.v24.i38.4393.","DOI":"10.3748\/wjg.v24.i38.4393"},{"key":"2025121815535097974_j_jpm-2025-0190_ref_025","doi-asserted-by":"crossref","unstructured":"Li, X, Zhang, W, Lin, J, Liu, H, Yang, Z, Teng, Y, et al.. Risk factors for adverse maternal and perinatal outcomes in women with preeclampsia: analysis of 1396 cases. J\u00a0Clin Hypertens 2018;20:1049\u201357. https:\/\/doi.org\/10.1111\/jch.13302.","DOI":"10.1111\/jch.13302"},{"key":"2025121815535097974_j_jpm-2025-0190_ref_026","doi-asserted-by":"crossref","unstructured":"Sato, S, Kawai, H, Sato, S, Iwasaki, H, Omori, M, Kita, Y, et al.. Hypertension and diabetes mellitus are associated with high FIB-4 index in a health checkup examination cohort without known liver disease. BMC Gastroenterol 2022;22:478. https:\/\/doi.org\/10.1186\/s12876-022-02575-5.","DOI":"10.1186\/s12876-022-02575-5"},{"key":"2025121815535097974_j_jpm-2025-0190_ref_027","doi-asserted-by":"crossref","unstructured":"Sugiyama, A, Kurisu, A, E, B, Ouoba, S, Ko, K, Rakhimov, A, et al.. Distribution of FIB-4 index in the general population: analysis of 75,666 residents who underwent health checkups. BMC Gastroenterol 2022;22:241. https:\/\/doi.org\/10.1186\/s12876-022-02290-1.","DOI":"10.1186\/s12876-022-02290-1"},{"key":"2025121815535097974_j_jpm-2025-0190_ref_028","doi-asserted-by":"crossref","unstructured":"\u00d6zer, S, G\u00fcne\u015f, H, \u00d6zer, A. FIB4 score is increased in severe preeclampsia. Turk J Biochem 2024;49:56\u201363. https:\/\/doi.org\/10.1515\/tjb-2022-0214.","DOI":"10.1515\/tjb-2022-0214"},{"key":"2025121815535097974_j_jpm-2025-0190_ref_029","doi-asserted-by":"crossref","unstructured":"Auger, N, Jutras, G, Paradis, G, Ayoub, A, Lewin, A, Maniraho, A, et al.. Long-term risk of chronic liver disease after pre-eclampsia. Int J Epidemiol 2025;54:dyaf072. https:\/\/doi.org\/10.1093\/ije\/dyaf072.","DOI":"10.1093\/ije\/dyaf072"},{"key":"2025121815535097974_j_jpm-2025-0190_ref_030","doi-asserted-by":"crossref","unstructured":"Hussain, FN, Rosenbluth, E, Feldman, KM, Strauss, TS, Schneider, E, Schmidt-Beauchat, E, et al.. Transient elastography and controlled attenuation parameter to evaluate hepatic steatosis and liver stiffness in postpartum patients. J\u00a0Matern Fetal Neonatal Med 2023;36:2190838. https:\/\/doi.org\/10.1080\/14767058.2023.2190838.","DOI":"10.1080\/14767058.2023.2190838"}],"container-title":["Journal of Perinatal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jpm-2025-0190\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jpm-2025-0190\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T15:54:26Z","timestamp":1766073266000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jpm-2025-0190\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,18]]},"references-count":30,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,7,28]]},"published-print":{"date-parts":[[2025,11,25]]}},"alternative-id":["10.1515\/jpm-2025-0190"],"URL":"https:\/\/doi.org\/10.1515\/jpm-2025-0190","relation":{},"ISSN":["0300-5577","1619-3997"],"issn-type":[{"value":"0300-5577","type":"print"},{"value":"1619-3997","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,18]]}}}